American Express
AXP
$313.59
-0.09%
American Express is a global financial institution operating in roughly 130 countries, providing consumer and business charge and credit card products alongside a highly profitable closed-loop merchant payment network; it reports through four segments — US Consumer Services, US Commercial Services, International Card Services, and Global Merchant and Network Services — and also offers expense management tools, consulting, and business lending to commercial clients. Its distinctiveness rests on a closed-loop model that captures both card-issuing economics (annual fees, net interest income, interchange) and network economics, giving it a premium-brand, fee-based identity that is structurally different from open-loop networks like Visa and Mastercard and from pure balance-sheet lenders. The current investor debate centers on whether the premium consumer remains resilient: Q2 2026 revenue grew 8.3% year over year to $21.6 billion with fee revenue reportedly up roughly 15%, yet the stock has de-rated sharply in 2026 (down about 15.9% YTD) as investors weigh credit normalization, a Q2 earnings miss, and a valuation that still embeds premium-brand pricing power. Coverage sentiment has turned incrementally constructive — JPMorgan upgraded to Overweight in July 2026 and Truist reiterated Buy in September — but the stock's persistent underperformance versus the S&P 500 keeps the growth-runway-versus-credit-cycle argument at the center of the narrative.…
AXP
American Express
$313.59
Related headlines
Investment Opinion: Should I buy AXP Today?
Rating: Hold with a constructive bias. The core thesis is that AXP's closed-loop franchise, 32.4% ROE, and 15% fee revenue growth are intact, but the stock lacks a near-term catalyst to reverse its 15.87% YTD decline, and the 25-analyst consensus 'buy' with a $369.44 average target already prices in a recovery. The risk/reward is balanced: 17.8% upside to the average target versus 7.2% downside to the 52-week low of $290.97.
Supporting evidence: forward PE of 15.56x on $28.70 estimated EPS is reasonable for a franchise with 85.9% gross margins and 14.4% net margins; TTM free cash flow of $15.05 billion provides a 5.9% FCF yield; revenue grew 8.34% year over year in Q2 2026; and the dividend payout ratio of 21.0% leaves room for continued buybacks. The stock's 24.0x trailing PE is above the forward multiple, implying the market expects earnings growth to close the gap, and the 17.8% upside to the average target is meaningful but not exceptional.
Risks and conditions: the biggest risks are a second consecutive earnings miss, accelerating credit losses, and further multiple compression toward the 15.56x forward PE. This Hold would upgrade to Buy if Q3 2026 results show fee revenue growth above 12% and credit losses stabilizing, or if the stock falls below $290 without a deterioration in fundamentals. It would downgrade to Sell if revenue growth decelerates below 5% or if net margin falls below 12%. Valuation verdict: fairly valued relative to history and peers, with a slight discount on forward earnings but a premium on book and sales.
Sign up to view all
AXP 12-Month Price Forecast
The forward-looking view is balanced: AXP's premium franchise and fee-based revenue mix are intact, but the stock's 15.87% YTD decline and Q2 earnings miss have damaged momentum. The 17.8% upside to the average analyst target is attractive, but the 7.2% downside to the 52-week low limits the risk/reward asymmetry. I would upgrade to bullish if Q3 2026 results show fee revenue growth above 15% and credit losses stabilizing, and downgrade to bearish if revenue growth falls below 5% or net margin drops below 12%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on American Express's 12-month outlook, with a consensus price target around $369.44 and implied upside of +17.8% versus the current price.
Average Target
$369.44
0 analysts
Implied Upside
+17.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$320 - $450
Analyst target range
Drowning in data?
Find the real signal!
Bulls vs Bears: AXP Investment Factors
The bear case currently has stronger near-term evidence: AXP has underperformed the S&P 500 by 27.8 percentage points YTD, missed Q2 earnings, and trades at 24x trailing earnings despite decelerating 8.3% revenue growth. However, the bull case is supported by 15% fee revenue growth, a 32.4% ROE, $15.05 billion in TTM free cash flow, and a 17.8% upside to the average analyst target of $369.44. The single most important tension is whether premium cardholder spending and credit quality hold up through the next two quarters; if fee growth stays near 15% and credit losses stabilize, the de-rating looks overdone, but a second consecutive earnings miss would validate the bear thesis and likely push the stock toward its 52-week low of $290.97.
Bullish
- Fee revenue growth signals premium resilience: Q2 2026 fee revenue reportedly grew ~15% year over year, far outpacing total revenue growth of 8.3%, indicating that the premium cardholder base continues to pay up for membership despite macro uncertainty. This fee-based mix is structurally higher-quality than interest income and supports the closed-loop brand moat.
- Analyst targets imply 17.8% upside: The 25-analyst consensus is 'buy' with an average target of $369.44, representing 17.8% upside from the $313.59 current price. Even the low target of $320 sits 2.0% above the current price, suggesting the sell-side sees limited further downside.
- Forward PE of 15.6x is undemanding: At a forward PE of 15.56x on estimated EPS of $28.70, AXP trades at a discount to its trailing PE of 24.0x and at a level that historically has marked attractive entry points for a franchise with 32.4% ROE. The PEG of 2.46 is elevated, but the forward multiple alone is not stretched for a premium financial.
- Profitability remains best-in-class: Q2 2026 net income of $3.11 billion on $21.6 billion revenue produced a 14.4% net margin, while gross margin reached 85.9% and operating margin 43.2%. ROE of 32.4% and ROA of 3.79% confirm the closed-loop model's earnings power even as credit normalizes.
Bearish
- Severe relative underperformance vs. S&P 500: AXP is down 15.87% YTD and 2.95% over one year, while the S&P 500 is up 11.93% and 15.53% respectively, producing relative strength of -27.80% YTD and -18.48% over 12 months. This persistent underperformance reflects a market that is actively de-rating the premium-consumer thesis.
- Q2 earnings miss and credit normalization: The company reported a Q2 2026 earnings miss, and the stock fell from $361.57 on July 16 to $326.17 by July 24, a 9.8% drawdown in six sessions. Credit normalization remains the central risk for a balance-sheet lender with $1.96 billion in quarterly interest expense.
- Valuation still embeds premium-brand pricing: Despite the YTD decline, AXP trades at 24.0x trailing earnings, 7.68x book, and 3.20x sales, with an EV/EBITDA of 17.16x. These multiples are not distressed and leave room for further compression if growth decelerates or credit costs rise.
- Leverage and thin current ratio: Debt-to-equity stands at 1.73x and the current ratio is only 0.284, reflecting the funding structure of a card lender. While normal for the industry, this leverage amplifies earnings sensitivity to credit losses and funding-cost changes.
AXP Technical Analysis
Beta
1.08
1.08x market volatility
Max Drawdown
-24.1%
Largest decline past year
52-Week Range
$291-$387
Price range past year
Annual Return
-2.9%
Cumulative gain past year
| Period | AXP Return | S&P 500 |
|---|---|---|
| 1m | +0.4% | +0.2% |
| 3m | -11.8% | +2.9% |
| 6m | -5.5% | +8.4% |
| 1y | -2.9% | +14.9% |
| ytd | -15.9% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AXP Fundamental Analysis
Quarterly Revenue
$21.6B
2026-06
Revenue YoY Growth
+8.3%
YoY Comparison
Gross Margin
85.9%
Latest Quarter
Free Cash Flow
$15.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AXP Overvalued?
PE
24.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 13x~20x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on credit normalization and leverage. AXP carries $1.96 billion in quarterly interest expense against $21.6 billion in Q2 revenue, and its debt-to-equity of 1.73x means a modest rise in charge-offs or funding costs flows directly to net income. The current ratio of 0.284 is structurally thin for a lender, and the Q2 earnings miss already demonstrated how quickly profitability can disappoint: net income of $3.11 billion translated to $4.54 EPS, below consensus expectations. Revenue concentration in US consumer and commercial card spending means a deterioration in premium cardholder behavior would hit both fee revenue and net interest income simultaneously.
Market and competitive risks include valuation compression and fintech disruption. At 24.0x trailing earnings, 7.68x book, and 3.20x sales, AXP trades at a premium that assumes continued pricing power; a further de-rating toward the forward PE of 15.56x would imply a price near $243, well below the 52-week low. The beta of 1.085 means the stock is modestly more volatile than the market, and with relative strength of -27.80% YTD, sector rotation away from financials would amplify losses. Competitors such as Affirm, whose Q4 earnings beat on strong GMV growth and rising card adoption, are encroaching on point-of-sale and younger-consumer spending, while open-loop networks Visa and Mastercard compete for merchant acceptance.
Worst-case scenario: a second consecutive earnings miss combined with rising credit losses and a market-wide multiple compression would likely drive AXP toward its 52-week low of $290.97, a 7.2% decline from the current $313.59. A more severe outcome, such as a recession-driven charge-off cycle that pushes the stock to the analyst low target of $320 (which is actually above the current price) is less punitive than a valuation-led de-rating to 15x forward EPS of $28.70, implying roughly $430 on the upside but a downside to $243 if the market applies a 15x multiple to a lowered EPS estimate. The maximum drawdown over the past year was -24.06%, and a repeat of that magnitude from the current price would take the stock to approximately $238, a loss of about 24%.
FAQ
The most severe risk is credit normalization: a rise in charge-offs would hit net income directly, and the Q2 2026 earnings miss already showed how sensitive the stock is to credit trends. Second is valuation compression: at 24.0x trailing earnings, a de-rating to 15x forward EPS would imply a price near $243, well below the 52-week low. Third is competitive disruption from fintechs like Affirm, whose Q4 earnings beat on strong GMV growth and rising card adoption, threatening AXP's younger-consumer base. Fourth is macro sensitivity: with a beta of 1.085 and relative strength of -27.80% YTD, a market downturn or sector rotation away from financials would amplify losses. Ranked by severity: credit risk, valuation risk, competitive risk, macro risk.
The 12-month forecast has three scenarios: a base case (50% probability) targeting $340-380, aligned with the analyst average of $369.44, assuming high-single-digit revenue growth and gradual credit normalization; a bull case (30% probability) targeting $400-450, aligned with the analyst high of $450, driven by sustained 15% fee revenue growth and credit stabilization; and a bear case (20% probability) targeting $260-300, near the 52-week low of $290.97, if a second earnings miss and rising credit losses trigger multiple compression. The base case is most likely, with the key assumption being that Q3 2026 results show no further deterioration in credit quality and that fee revenue growth remains above 12%.
AXP is fairly valued to slightly undervalued on forward earnings but carries a premium on book and sales. The forward PE of 15.56x is below the trailing PE of 24.0x, implying the market expects EPS to grow to $28.70, and it is in line with historical averages for a premium financial. However, the price-to-book of 7.68x and price-to-sales of 3.20x are rich relative to traditional banks, reflecting the closed-loop network's higher margins. The PEG ratio of 2.46 suggests the market is paying up for growth, and the 17.8% upside to the average target implies the stock is modestly undervalued relative to analyst expectations. Overall, the valuation is not stretched enough to call it overvalued, but it is not a deep-value opportunity either.
From a risk/reward perspective, AXP offers 17.8% upside to the average analyst target of $369.44 against 7.2% downside to the 52-week low of $290.97, a roughly 2.5:1 reward-to-risk ratio that is attractive but not exceptional. The stock trades at 15.56x forward earnings, which is reasonable for a franchise with 32.4% ROE and 15% fee revenue growth, but the Q2 earnings miss and 15.87% YTD decline show that momentum is negative. It is a good buy for long-term investors who believe premium cardholder spending will remain resilient and who can tolerate a potential 24% drawdown (the past year's max drawdown) in a recession scenario. Short-term traders should wait for a confirmed reversal above the $340 level or a successful retest of the 52-week low.
AXP is better suited for long-term investment than short-term trading. The stock's beta of 1.085 and 24.06% max drawdown over the past year indicate meaningful volatility, and the current de-rating phase could take several quarters to resolve. The dividend yield of 0.88% is modest, so total return depends on capital appreciation, which requires patience for the premium-consumer thesis to reassert itself. Earnings visibility is moderate: the 25-analyst consensus with a $369.44 target suggests a 12-18 month horizon for the thesis to play out. A suggested minimum holding period is 18-24 months, allowing time for credit normalization to peak and for the forward PE of 15.56x to be validated by EPS growth toward $28.70.